In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...

This is read by an automated voice. Please report any issues or inconsistencies here. President Trump says that “Republicans” should “nationalize the election” or at least take over voting in up to 15 ...

This is read by an automated voice. Please report any issues or inconsistencies here. Starting next month, travelers who want to board a domestic flight without a Real ID will have to pay $45 to have ...

(NEXSTAR) – If you’re planning to board a plane in the coming weeks and aren’t REAL ID-compliant, you could find yourself forking over a $45 fee soon. Last spring, the national minimum requirement for ...

African Muslim Yarrow Mamout rose from a life of slavery to become a popular businessman in Washington, D.C. Artist Charles Willson Peale painted his portrait and discovered his incredible story.

Last Sunday, after a weekend of skiing in Lake Tahoe, I headed west and traversed mountainous scenic roads so whimsical every turn felt like a drive through Dr. Seuss’ Whoville. I walked a quarter of ...

LOCATION TAG — Generations Ahead has appointed Yarrow Brown as its new Executive Director, effective Feb. 2, 2026. Brown will succeed Marjie Rich, who retired in August 2025 after eight years of ...

Photographer in Durango for photo shoot, reception held Friday at Sorrel Sky Gallery For photographer David Yarrow, his latest book, “The Collection,” was a chance to look back over decades of work.

Can you use a passport instead of a REAL ID? Yes. Can you use a REAL ID instead of a passport? No. Starting Feb. 1, airline passengers without an acceptable form of ID can verify their ID using TSA ...

(Alliance News) - RTW Biotech Opportunities Ltd on Thursday said it participated in the series A funding round of clinical stage biotechnology company Yarrow Bioscience Inc ahead of its Nasdaq listing ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”) and Yarrow Bioscience, Inc. (“Yarrow”) today announced that they have entered into a definitive merger ...

Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) ...